Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 7
1965 1
1967 1
1968 3
1969 1
1970 4
1971 1
1972 1
1973 2
1974 3
1977 5
1980 6
1982 5
1984 3
1985 10
1986 4
1987 3
1988 6
1989 4
1990 2
1991 5
1992 4
1993 2
1994 3
1995 3
1996 2
1997 3
1998 4
1999 3
2000 3
2001 1
2002 5
2004 4
2005 1
2006 2
2007 7
2008 10
2009 7
2010 8
2011 11
2012 9
2013 5
2014 7
2015 10
2016 11
2017 11
2018 17
2019 20
2020 21
2021 22
2022 17
2023 17
2024 15
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

321 results

Results by year

Filters applied: . Clear all
Page 1
The mitochondrial intermembrane space protein mitofissin drives mitochondrial fission required for mitophagy.
Fukuda T, Furukawa K, Maruyama T, Yamashita SI, Noshiro D, Song C, Ogasawara Y, Okuyama K, Alam JM, Hayatsu M, Saigusa T, Inoue K, Ikeda K, Takai A, Chen L, Lahiri V, Okada Y, Shibata S, Murata K, Klionsky DJ, Noda NN, Kanki T. Fukuda T, et al. Among authors: takai a. Mol Cell. 2023 Jun 15;83(12):2045-2058.e9. doi: 10.1016/j.molcel.2023.04.022. Epub 2023 May 15. Mol Cell. 2023. PMID: 37192628 Free PMC article.
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.
Ueno M, Takeda H, Takai A, Morimura H, Nishijima N, Iwamoto S, Okuyama S, Umeda M, Seta T, Ikeda A, Goto T, Miyamoto S, Kayahara T, Uenoyama Y, Matsumura K, Nakano S, Mishima M, Inuzuka T, Eso Y, Takahashi K, Marusawa H, Osaki Y, Hatano E, Seno H. Ueno M, et al. Among authors: takai a. J Gastroenterol. 2024 Dec;59(12):1107-1118. doi: 10.1007/s00535-024-02150-7. Epub 2024 Sep 18. J Gastroenterol. 2024. PMID: 39289234 Free PMC article.
Genetic Landscape of Multistep Hepatocarcinogenesis.
Takeda H, Takai A, Eso Y, Takahashi K, Marusawa H, Seno H. Takeda H, et al. Among authors: takai a. Cancers (Basel). 2022 Jan 23;14(3):568. doi: 10.3390/cancers14030568. Cancers (Basel). 2022. PMID: 35158835 Free PMC article. Review.
Population pharmacokinetic analysis of bevacizumab in Japanese cancer patients with proteinuria: a prospective cohort study.
Masuda T, Funakoshi T, Horimatsu T, Masui S, Hira D, Inoue M, Yajima K, Nakagawa S, Ikemi Y, Hamanishi J, Takai A, Yamamoto S, Matsubara T, Mandai M, Seno H, Yanagita M, Muto M, Terada T, Yonezawa A. Masuda T, et al. Among authors: takai a. Cancer Chemother Pharmacol. 2025 Mar 21;95(1):46. doi: 10.1007/s00280-025-04769-6. Cancer Chemother Pharmacol. 2025. PMID: 40116970
321 results